Skip to content

Insider · CIK 0001783992

Kevin R Thornal

ceopresidentofficerdirector

Files at ZBH (ZIMMER BIOMET HOLDINGS, INC.), NVRO (NEVRO CORP). First filing Sep 15, 2026, latest Sep 15, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $529k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ZBH: ZIMMER BIOMET HOLDINGS, INC.

ZBHOct 9, 2026 · close 89.14

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
61Notable
ZBHsell 2
ZIMMER BIOMET HOLDINGS, INC.
$529k
5,691 shares
-100%+18% from low-9% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026ZBH
ZIMMER BIOMET HOLDINGS, INC.
SOpen-market sale
Common Stock
-5,691$92.95$529k027 d ago
Apr 3, 2025NVRO
NEVRO CORP
DDisposition to issuer
Common Stock
-852,337--0Apr 3, 2025
Oct 24, 2024NVRO
NEVRO CORP
FTax withholding
Common Stock
-6,063$4.85$29k249,847Oct 28, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kevin R Thornal: insider trades and track record | InsiderTell